Nuveen Asset Management, LLC - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 237 filers reported holding BALCHEM CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of BALCHEM CORP
ValueSharesWeighting
Q2 2024$20,459,647
-0.2%
132,898
+0.4%
0.01%0.0%
Q1 2024$20,505,464
+4.9%
132,336
+0.7%
0.01%0.0%
Q4 2023$19,541,968
+24.8%
131,367
+4.1%
0.01%0.0%
Q3 2023$15,655,957
-7.8%
126,217
+0.2%
0.01%0.0%
Q2 2023$16,989,296
+136535.8%
126,024
+28.2%
0.01%
+20.0%
Q1 2023$12,434
-10.8%
98,314
-13.9%
0.01%0.0%
Q4 2022$13,943
-99.9%
114,184
-13.8%
0.01%
-28.6%
Q3 2022$16,114,000
-3.5%
132,535
+3.0%
0.01%
+16.7%
Q2 2022$16,697,000
-10.1%
128,695
-3.0%
0.01%0.0%
Q1 2022$18,573,000
-46.1%
132,674
-35.1%
0.01%
-40.0%
Q4 2021$34,482,000
+9.8%
204,522
-8.8%
0.01%0.0%
Q3 2021$31,400,000
-6.0%
224,256
-11.8%
0.01%0.0%
Q2 2021$33,388,000
-14.3%
254,367
-18.1%
0.01%
-16.7%
Q1 2021$38,952,000
+4.1%
310,594
-4.3%
0.01%
-7.7%
Q4 2020$37,409,000
+17.4%
324,677
-0.5%
0.01%
+8.3%
Q3 2020$31,868,000
+67.9%
326,419
+63.1%
0.01%
+50.0%
Q2 2020$18,982,000
+26.7%
200,101
+31.8%
0.01%
+14.3%
Q1 2020$14,987,000
+13.3%
151,814
+16.7%
0.01%
+40.0%
Q4 2019$13,224,000
+4.0%
130,125
+1.5%
0.01%0.0%
Q3 2019$12,711,000
-6.6%
128,146
-5.9%
0.01%0.0%
Q2 2019$13,608,000136,1250.01%
Other shareholders
BALCHEM CORP shareholders Q2 2019
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 203,004$25,18119.44%
Montanaro Asset Management Ltd 188,000$23,319,5204.10%
Conestoga Capital Advisors, LLC 1,076,327$133,507,6482.29%
GENEVA CAPITAL MANAGEMENT LLC 763,326$94,682,9372.00%
Tributary Capital Management, LLC 139,116$17,255,9491.63%
WASATCH ADVISORS LP 1,976,930$245,218,3971.55%
Cutter & CO Brokerage, Inc. 41,853$5,191,4091.52%
Laurus Investment Counsel Inc. 19,990$3,342,1741.40%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 37,950$4,707,3180.97%
MOODY ALDRICH PARTNERS LLC 36,613$4,541,4770.86%
View complete list of BALCHEM CORP shareholders